Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 14 de 14
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Ear Hear ; 45(2): 329-336, 2024.
Article de Anglais | MEDLINE | ID: mdl-37700446

RÉSUMÉ

OBJECTIVES: To evaluate the extent of hearing loss among pottery workers in Mexico exposed to lead. DESIGN: The authors conducted a cross-sectional study including 315 adult pottery workers. Auditory function was evaluated by air conduction pure-tone audiometry (pure-tone average) and distortion-product otoacoustic emission (DPOAE) levels (amplitude and signal-to-noise ratio). Lead exposure was assessed with a single blood sample test and classified as low, medium, and high according to blood lead tertiles. Logistic regression models were calculated for the association between blood lead levels, pure-tone average, and DPOAE records. RESULTS: Median (25th-75th) blood lead levels were 14 µg/dL (7.5-22.6 µg/dL). The audiometric pattern and DPOAE records were similar across blood lead levels groups in all frequencies, and no statistically significant differences were found. Adjusted logistic regression models showed no increase in the odds for hearing thresholds >25 dB (HL) and DPOAE absence associated with blood lead levels, and no dose-response pattern was observed ( p > 0.05). CONCLUSIONS: Given the results from this cross-sectional study, no association was found between blood lead levels and hearing loss assessed with DPOAE. Future longitudinal work should consider chronic lead exposure estimates among underrepresented populations, which can potentially inform safer work practices to minimize the risk of ototoxicity.


Sujet(s)
Surdité , Perte d'audition , Ototoxicité , Adulte , Humains , Plomb , Ototoxicité/étiologie , Études transversales , Seuil auditif/physiologie , Émissions otoacoustiques spontanées/physiologie , Perte d'audition/induit chimiquement , Audiométrie tonale/méthodes
2.
J Nephrol ; 36(5): 1383-1393, 2023 06.
Article de Anglais | MEDLINE | ID: mdl-37253904

RÉSUMÉ

BACKGROUND: In recent years, chronic kidney disease has increased in the pediatric population and has been related to environmental factors. In the diagnosis of kidney damage, in addition to the traditional parameters, early kidney damage biomarkers, such as kidney injury molecule 1, cystatin C, and osteopontin, among others, have been implemented as predictors of early pathological processes. OBJECTIVE: This study aimed to evaluate the relationship between exposure to environmental pollutants and early kidney damage biomarkers. METHODS: A cross-sectional pilot study was conducted in February 2016 and involved 115 apparently healthy children aged 6-15 residing in Apizaco, Tlaxcala. Participant selection was carried out randomly from among 16,472 children from the municipality of Apizaco. A socio-demographic questionnaire included  age, sex, education, duration of residence in the area, occupation, water consumption and dietary habits, pathological history, and some non-specific symptoms. Physical examination included blood pressure, weight, and height. The urine concentrations of urinary aluminum, total arsenic, boron, calcium, chromium, copper, mercury, potassium, sodium, magnesium, manganese, molybdenum, lead, selenium, silicon, thallium, vanadium, uranium, and zinc, were measured. Four of the 115 participants selected for the study were excluded due to an incomplete questionnaire or lack of a medical examination, leaving a final sample population of 111 participants. RESULTS: The results showed a mean estimated glomerular filtration rate of 89.1 ± 9.98 mL/min/1.73m2 and a mean albumin/creatinine ratio of 12.9 ± 16.7 mg/g urinary creatinine. We observed a positive and significant correlation between estimated glomerular filtration rate with fluoride, total arsenic and lead, and a correlation of albumin/creatinine ratio with fluoride, vanadium, and total arsenic. There was also a significant correlation between the early kidney damage biomarkers and fluoride, vanadium, and total arsenic, except for cystatin C. CONCLUSION: In conclusion, our results show that four urinary biomarkers: α1-microglobulin, cystatin C, kidney injury molecule 1, and neutrophil gelatinase-associated lipocalin are related to environmental exposure to urinary fluoride, vanadium, and total arsenic in our pediatric population.


Sujet(s)
Arsenic , Insuffisance rénale chronique , Humains , Enfant , Arsenic/effets indésirables , Arsenic/analyse , Cystatine C , Fluorures , Vanadium , Mexique/épidémiologie , Études transversales , Créatinine , Projets pilotes , Rein , Marqueurs biologiques , Albumines , Débit de filtration glomérulaire , Lipocaline-2
3.
Biomed Res Int ; 2015: 175025, 2015.
Article de Anglais | MEDLINE | ID: mdl-26339590

RÉSUMÉ

Inorganic arsenic (iAs) exposure induces a decrease in glucose type 4 transporter (GLUT4) expression on the adipocyte membrane, which may be related to premature births and low birth weight infants in women exposed to iAs at reproductive age. The aim of this study was to analyze the effect of sodium arsenite (NaAsO2) exposure on GLUT1, GLUT3, and GLUT4 protein expression and on placental morphology. Female Balb/c mice (n = 15) were exposed to 0, 12, and 20 ppm of NaAsO2 in drinking water from 8th to 18th day of gestation. Morphological changes and GLUT1, GLUT3, and GLUT4 expression were evaluated in placentas by immunohistochemical and image analysis and correlated with iAs and arsenical species concentration, which were quantified by atomic absorption spectroscopy. NaAsO2 exposure induced a significant decrease in fetal and placental weight (P < 0.01) and increases in infarctions and vascular congestion. Whereas GLUT1 expression was unchanged in placentas from exposed group, GLUT3 expression was found increased. In contrast, GLUT4 expression was significantly lower (P < 0.05) in placentas from females exposed to 12 ppm. The decrease in placental GLUT4 expression might affect the provision of adequate fetal nutrition and explain the low fetal weight observed in the exposed groups.


Sujet(s)
Arsénites/toxicité , Transporteur de glucose de type 1/biosynthèse , Transporteur de glucose de type 2/biosynthèse , Transporteur de glucose de type 4/biosynthèse , Composés du sodium/toxicité , Adipocytes/effets des médicaments et des substances chimiques , Adipocytes/anatomopathologie , Animaux , Femelle , Régulation de l'expression des gènes au cours du développement/effets des médicaments et des substances chimiques , Glucose/métabolisme , Transporteur de glucose de type 1/génétique , Transporteur de glucose de type 2/génétique , Transporteur de glucose de type 4/génétique , Humains , Nourrisson à faible poids de naissance/métabolisme , Souris , Placenta/effets des médicaments et des substances chimiques , Placenta/métabolisme , Placenta/anatomopathologie , Grossesse , Naissance prématurée/induit chimiquement , Naissance prématurée/génétique , Naissance prématurée/anatomopathologie , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Effets différés de l'exposition prénatale à des facteurs de risque/génétique , Effets différés de l'exposition prénatale à des facteurs de risque/anatomopathologie , Spectrophotométrie atomique
4.
Pharmacol Ther ; 142(2): 206-30, 2014 May.
Article de Anglais | MEDLINE | ID: mdl-24333264

RÉSUMÉ

Oxidative stress is a common hallmark of neuronal cell death associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, as well as brain stroke/ischemia and traumatic brain injury. Increased accumulation of reactive species of both oxygen (ROS) and nitrogen (RNS) has been implicated in mitochondrial dysfunction, energy impairment, alterations in metal homeostasis and accumulation of aggregated proteins observed in neurodegenerative disorders, which lead to the activation/modulation of cell death mechanisms that include apoptotic, necrotic and autophagic pathways. Thus, the design of novel antioxidant strategies to selectively target oxidative stress and redox imbalance might represent important therapeutic approaches against neurological disorders. This work reviews the evidence demonstrating the ability of genetically encoded antioxidant systems to selectively counteract neuronal cell loss in neurodegenerative diseases and ischemic brain damage. Because gene therapy approaches to treat inherited and acquired disorders offer many unique advantages over conventional therapeutic approaches, we discussed basic research/clinical evidence and the potential of virus-mediated gene delivery techniques for antioxidant gene therapy.


Sujet(s)
Antioxydants/métabolisme , Thérapie génétique/méthodes , Dégénérescence nerveuse , Régénération nerveuse , Maladies neurodégénératives/thérapie , Neurones/métabolisme , Stress oxydatif , Animaux , Mort cellulaire , Techniques de transfert de gènes , Vecteurs génétiques , Humains , Maladies neurodégénératives/génétique , Maladies neurodégénératives/métabolisme , Maladies neurodégénératives/anatomopathologie , Maladies neurodégénératives/physiopathologie , Neurones/anatomopathologie , Stress oxydatif/génétique , Virus/génétique
5.
Biol Trace Elem Res ; 156(1-3): 279-87, 2013 Dec.
Article de Anglais | MEDLINE | ID: mdl-24218229

RÉSUMÉ

Selenium (Se) is an essential component of several major metabolic pathways and controls immune function. Arsenic (As) is a human carcinogen with immunotoxic and genotoxic activities, functioning mainly by producing oxidative stress. Due to the ability of Se to interact with As and to possibly block its toxic effects, we investigated the impact of dietary Se-methionine (Se-Met) supplementation on the toxicity of As exposure in vivo in a mouse model. Sufficient and excess levels of Se-Met (0.2 and 2 ppm, respectively) were fed to C57BL/6N female mice exposed to sodium arsenite (3, 6 and 10 mg/kg) in tap water for 9 days. We observed that As exposure increased Se-Met excretion in the urine. Se-Met supplementation increased the relative liver weight and decreased the concentration of total liver proteins in animals exposed to 10 mg/kg of As. Se-Met supplementation maintained a normal pool of glutathione in the liver and increased glutathione peroxidase concentration, although the lipoperoxidation level was increased by Se-Met even without As exposure. Se-Met supplementation helped to maintain the CD4/CD8 ratio of lymphocytes in the spleen, although it increased the proportion of B cells. Se-Met supplementation prior to As exposure increased the secretion of interleukin-4, IL-12 and interferon-γ and the stimulation index of the spleen cells in in vitro assays. Se-Met intake improved the basal immunological parameters but did not reduce the damage caused by oxidative stress after low-dose As exposure.


Sujet(s)
Arsénites/toxicité , Cancérogènes/toxicité , Compléments alimentaires , Sélénométhionine , Composés du sodium/toxicité , Animaux , Arsenic/toxicité , Antienzymes/toxicité , Femelle , Glutathion/métabolisme , Humains , Interleukine-12/métabolisme , Interleukine-4/métabolisme , Foie/métabolisme , Foie/anatomopathologie , Souris , Stress oxydatif/effets des médicaments et des substances chimiques , Sélénométhionine/pharmacologie , Sélénométhionine/urine , Rate/métabolisme , Rate/anatomopathologie
6.
Chem Res Toxicol ; 25(1): 216-24, 2012 Jan 13.
Article de Anglais | MEDLINE | ID: mdl-22136492

RÉSUMÉ

Glutathione S-transferases, including GST-T1 and GST-M1, are known to be involved in the phase II detoxification pathways for xenobiotics as well as in the metabolism of endogenous compounds. Polymorphisms in these genes have been linked to an increased susceptibility to carcinogenesis and associated with risk factors that predispose to certain inflammatory diseases. In addition, GST-T1 and GST-M1 null genotypes have been shown to be responsible for interindividual variations in the metabolism of arsenic, a known human carcinogen. To assess the specific GST genotypes in the Mexican population chronically exposed to arsenic, we have developed a multiplex High Resolution Melting PCR (HRM-PCR) analysis using a LightCycler480 instrument. This method is based on analysis of the PCR product melting curve that discriminates PCR products according to their lengths and base sequences. Three pairs of primers that specifically recognize GST-T1, GST-M1, and ß-globin, an internal control, to produce amplicons of different length were designed and combined with LightCycler480 High Resolution Melting Master Mix containing ResoLight, a completely saturating DNA dye. Data collected from melting curve analysis were evaluated using LightCycler480 software to determine specific melting temperatures of individual melting curves representing target genes. Using this newly developed multiplex HRM-PCR analysis, we evaluated GST-T1 and GST-M1 genotypes in 504 DNA samples isolated from the blood of individuals residing in Zimapan, Lagunera, and Chihuahua regions in Mexico. We found that the Zimapan and Lagunera populations have similar GST-T1 and GST-M1 genotype frequencies which differ from those of the Chihuahua population. In addition, 14 individuals have been identified as carriers of the double null genotype, i.e., null genotypes in both GST-T1 and GST-M1 genes. Although this procedure does not distinguish between biallelic (+/+) and monoallelic (+/-) genotypes, it can be used in an automated workflow as a simple, sensitive, and time and money saving procedure for rapid identification of the GST-T1 and GST-M1 positive or null genotypes.


Sujet(s)
Génotype , Glutathione transferase/génétique , Réaction de polymérisation en chaine multiplex/méthodes , Adulte , Sujet âgé , ADN/génétique , Femelle , Hépatocytes/enzymologie , Humains , Mâle , Mexique , Adulte d'âge moyen , Polymorphisme génétique , Globines bêta/génétique
7.
Chem Res Toxicol ; 24(2): 165-7, 2011 Feb 18.
Article de Anglais | MEDLINE | ID: mdl-21291286

RÉSUMÉ

Inorganic arsenic (iAs) is an environmental toxicant currently poisoning millions of people worldwide, and chronically exposed individuals are susceptible to arsenicosis or arsenic poisoning. Using a state-of-the-art technique to map the methylomes of our study subjects, we identified a large interactome of hypermethylated genes that are enriched for their involvement in arsenic-associated diseases, such as cancer, heart disease, and diabetes. Notably, we have uncovered an arsenic-induced tumor suppressorome, a complex of 17 tumor suppressors known to be silenced in human cancers. This finding represents a pivotal clue in unraveling a possible epigenetic mode of arsenic-induced disease.


Sujet(s)
Intoxication par l'arsenic/génétique , Arsenic/toxicité , Épigenèse génétique , Polluants chimiques de l'eau/toxicité , Ilots CpG , Méthylation de l'ADN , Exposition environnementale/effets indésirables , Humains , Mexique , Alimentation en eau
8.
J Appl Toxicol ; 31(6): 579-88, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21089161

RÉSUMÉ

Fluorosis, caused by drinking water contaminated with inorganic fluoride, is a public health problem in many areas around the world. The aim of this study was to evaluate oxidative stress in spermatozoa caused by fluoride and NADPH oxidase in relationship to fluoride. Four experimental groups of male Wistar rats were administered with deionized water, NaF, at a dose equivalent to 5 mg fluoride kg⁻¹ per 24 h, NaF plus 20 mg kg⁻¹ per 24 h α-tocopherol, or α-tocopherol alone for 60 days. We evaluated several spermatozoa parameters in the four groups: standard quality analysis, superoxide dismutase (SOD) activity, the generation of reactive oxygen species (ROS), NADPH oxidase activity, TBARS formation, ultrastructural analyses of spermatozoa using transmission electron microscopy and in vitro fertilization (IVF) capacity. After 60 days of treatment, urinary excretion of fluoride was not modified by α-tocopherol. Spermatozoa from fluoride-treated rats exhibited a significant increase in the generation of ROS, accompanied by a significant increase in NADPH oxidase activity. The increase in ROS generation was significantly diminished by diphenylene iodonium, an inhibitor of NADPH oxidase activity. In contrast, a decrease in the generation of ROS, an increase in SOD activity and the prevention of TBARS formation process were observed in spermatozoa of rats exposed to fluoride plus α-tocopherol. Finally, α-tocopherol treatment prevented the IVF incapacity observed in the spermatozoa from fluoride-treated rats. These results suggest that NADPH oxidase participates in the oxidative stress damage caused by subchronic exposure to fluoride.


Sujet(s)
Antioxydants/pharmacologie , Fluorures/toxicité , NADPH oxidase/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Spermatozoïdes/effets des médicaments et des substances chimiques , alpha-Tocophérol/pharmacologie , Animaux , Mâle , Microscopie électronique à transmission , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolisme , Spermatozoïdes/anatomopathologie , Substances réactives à l'acide thiobarbiturique/métabolisme , Tests de toxicité subchronique
9.
Chem Biol Interact ; 188(2): 319-33, 2010 Nov 05.
Article de Anglais | MEDLINE | ID: mdl-20650267

RÉSUMÉ

Halfway through the twentieth century, fluoride piqued the interest of toxicologists due to its deleterious effects at high concentrations in human populations suffering from fluorosis and in in vivo experimental models. Until the 1990s, the toxicity of fluoride was largely ignored due to its "good reputation" for preventing caries via topical application and in dental toothpastes. However, in the last decade, interest in its undesirable effects has resurfaced due to the awareness that this element interacts with cellular systems even at low doses. In recent years, several investigations demonstrated that fluoride can induce oxidative stress and modulate intracellular redox homeostasis, lipid peroxidation and protein carbonyl content, as well as alter gene expression and cause apoptosis. Genes modulated by fluoride include those related to the stress response, metabolic enzymes, the cell cycle, cell-cell communications and signal transduction. The primary purpose of this review is to examine recent findings from our group and others that focus on the molecular mechanisms of the action of inorganic fluoride in several cellular processes with respect to potential physiological and toxicological implications. This review presents an overview of the current research on the molecular aspects of fluoride exposure with emphasis on biological targets and their possible mechanisms of involvement in fluoride cytotoxicity. The goal of this review is to enhance understanding of the mechanisms by which fluoride affects cells, with an emphasis on tissue-specific events in humans.


Sujet(s)
Cariostatiques/toxicité , Fluorures/toxicité , Apoptose , Cariostatiques/métabolisme , Fluorures/métabolisme , Régulation de l'expression des gènes , Humains , Stress oxydatif , Transduction du signal
10.
J Hazard Mater ; 178(1-3): 450-4, 2010 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-20189716

RÉSUMÉ

This paper reports arsenic methylation in betaine-nontronite clay-water suspensions under environmental conditions. Two nontronites (<0.05 mm), NAu-1 (green color, Al-enriched) and NAu-2 (brown color, Al-poor, contains tetrahedral Fe) from Uley Mine - South Australia were selected for this study. Betaine (pK(a)=1.83) was selected as methyl donor. The reaction between 5 g L(-1) clay, 20 ppm As(III), and 0.4M betaine at 7< or =pH(0)< or =9 under anoxic conditions was studied. The presence of nontronite clays were found to favor As(III) conversion to monomethylarsenic (MMA). Arsenic conversion was found to be as high as 50.2 ng MMA/ng As(III)(0). Conversion of As was found to be more quantitative in the presence of NAu-2 ((Na(0.72)) [Si(7.55) Al(0.16)Fe(0.29)][Al(0.34) Fe(3.54) Mg(0.05)] O(20)(OH)(4)) than NAu-1 ((Na(1.05)) [Si(6.98) Al(0.95)Fe(0.07)][Al(0.36) Fe(3.61) Mg(0.04)] O(20)(OH)(4)). The inherent negative charge at the nontronite tetrahedral layer stabilizes positively charged organic intermediate-reaction species, thereby leading to decreases in the overall methylation activation energy. The outcome of this work shows that nontronite clays catalyze As methylation to MMA via non-enzymatic pathway(s) under environmental conditions.


Sujet(s)
Silicates d'aluminium/composition chimique , Composés de l'arsenic/composition chimique , Bétaïne/composition chimique , Polluants du sol/composition chimique , Aluminium/composition chimique , Argile , Fer/composition chimique , Méthylation , Minéraux/composition chimique , Taille de particule , Sol/analyse , Solutions , Propriétés de surface , Suspensions , Température , Eau/composition chimique
11.
Toxicol Appl Pharmacol ; 230(3): 352-7, 2008 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-18455746

RÉSUMÉ

Fluorosis, caused by drinking water contamination with inorganic fluoride, is a public health problem in many areas around the world. The aim of the study was to evaluate the effect of environmentally relevant doses of fluoride on in vitro fertilization (IVF) capacity of spermatozoa, and its relationship to spermatozoa mitochondrial transmembrane potential (DeltaPsi(m)). Male Wistar rats were administered at 5 mg fluoride/kg body mass/24 h, or deionized water orally for 8 weeks. We evaluated several spermatozoa parameters in treated and untreated rats: i) standard quality analysis, ii) superoxide dismutase (SOD) activity, iii) the generation of superoxide anion (O(2)(-)), iv) lipid peroxidation concentration, v) ultrastructural analyses of spermatozoa using transmission electron microscopy, vi) DeltaPsi(m), vii) acrosome reaction, and viii) IVF capability. Spermatozoa from fluoride-treated rats exhibited a significant decrease in SOD activity (~33%), accompanied with a significant increase in the generation of O(2)() (~40%), a significant decrease in DeltaPsi(m) (~33%), and a significant increase in lipid peroxidation concentration (~50%), relative to spermatozoa from the control group. Consistent with this finding, spermatozoa from fluoride-treated rats exhibited altered plasmatic membrane. In addition, the percentage of fluoride-treated spermatozoa capable of undergoing the acrosome reaction was decreased relative to control spermatozoa (34 vs. 55%), while the percentage fluoride-treated spermatozoa capable of oocyte fertilization was also significantly lower than the control group (13 vs. 71%). These observations suggest that subchronic exposure to fluoride causes oxidative stress damage and loss of mitochondrial transmembrane potential, resulting in reduced fertility.


Sujet(s)
Fécondité/effets des médicaments et des substances chimiques , Fluorures/toxicité , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Spermatozoïdes/effets des médicaments et des substances chimiques , Réaction acrosomique/effets des médicaments et des substances chimiques , Animaux , Fécondation in vitro , Mâle , Rats , Rat Wistar , Mobilité des spermatozoïdes/effets des médicaments et des substances chimiques , Spermatozoïdes/ultrastructure
12.
Environ Res ; 104(3): 383-9, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17475235

RÉSUMÉ

Inorganic arsenic exposure in drinking water has been recently related to diabetes mellitus. To evaluate this relationship the authors conducted in 2003, a case-control study in an arseniasis-endemic region from Coahuila, a northern state of Mexico with a high incidence of diabetes. The present analysis includes 200 cases and 200 controls. Cases were obtained from a previous cross-sectional study conducted in that region. Diagnosis of diabetes was established following the American Diabetes Association criteria, with two fasting glucose values > or = 126 mg/100 ml (> or = 7.0 mmol/l) or a history of diabetes treated with insulin or oral hypoglycemic agents. The next subject studied, subsequent to the identification of a case in the cross-sectional study was taken as control. Inorganic arsenic exposure was measured through total arsenic concentrations in urine, measured by hydride-generation atomic absorption spectrophotometry. Subjects with intermediate total arsenic concentration in urine (63.5-104 microg/g creatinine) had two-fold higher risk of having diabetes (odds ratio=2.16; 95% confidence interval: 1.23, 3.79), but the risk was almost three times greater in subjects with higher concentrations of total arsenic in urine (odds ratio=2.84; 95% confidence interval: 1.64, 4.92). This data provides additional evidence that inorganic arsenic exposure may be diabetogenic.


Sujet(s)
Intoxication par l'arsenic , Composés de l'arsenic/urine , Diabète de type 2 , Exposition environnementale , Polluants chimiques de l'eau , Alimentation en eau/normes , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Intoxication par l'arsenic/complications , Intoxication par l'arsenic/urine , Études cas-témoins , Études transversales , Diabète de type 2/épidémiologie , Diabète de type 2/étiologie , Diabète de type 2/urine , Exposition environnementale/effets indésirables , Exposition environnementale/analyse , Femelle , Humains , Modèles logistiques , Mâle , Mexique/épidémiologie , Adulte d'âge moyen , Analyse multifactorielle , Polluants chimiques de l'eau/toxicité , Polluants chimiques de l'eau/urine
13.
Food Chem Toxicol ; 45(7): 1147-53, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17306430

RÉSUMÉ

Many studies evaluating the effects of selenium (Se) status on immunity utilize inorganic Se, although selenomethionine (Se-Met) has been suggested to be more bioavailable and less toxic. In the current study, we investigated the effects of dietary Se-Met on immune system function and cellular redox status in C57BL/6N female mice fed with low (0.02 ppm), sufficient (0.2 ppm, control group), or excess Se-Met (2 ppm) in the diet for 50 days. Low Se-Met intake reduced glutathione peroxidase (GPx) activity and glutathione concentration without modifying lipoperoxidation. While low Se-Met intake also reduced the number of B cells in the spleen, it increased mitogen-induced proliferation, IL-4 and IL-12 secretion when compared to the sufficient Se-Met intake group. In comparison to controls, excess Se-Met intake increased splenocyte proliferation and reduced B cell numbers, IL-4, and IL-12 secretion without affecting oxidative stress markers. These data suggest that Se-Met supplementation should be carefully evaluated as it many influence immune function.


Sujet(s)
Antioxydants/administration et posologie , Système immunitaire/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Sélénométhionine/administration et posologie , Rate/effets des médicaments et des substances chimiques , Animaux , Antioxydants/toxicité , Lymphocytes B/effets des médicaments et des substances chimiques , Lymphocytes B/anatomopathologie , Marqueurs biologiques/métabolisme , Prolifération cellulaire/effets des médicaments et des substances chimiques , Régime alimentaire , Relation dose-effet des médicaments , Femelle , Glutathion/métabolisme , Glutathione peroxidase/métabolisme , Système immunitaire/anatomopathologie , Interleukine-12/métabolisme , Interleukine-4/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Souris , Souris de lignée C57BL , Sélénométhionine/toxicité , Rate/immunologie , Rate/métabolisme , Rate/anatomopathologie , Prise de poids/effets des médicaments et des substances chimiques
14.
Biol Trace Elem Res ; 108(1-3): 115-26, 2005.
Article de Anglais | MEDLINE | ID: mdl-16327065

RÉSUMÉ

The aim of this work is based in the premise that inorganic arsenic (AsIII) and trivalentmethylated metabolites monomethylarsonous (MMAIII) and dimethylarsinous (DMAIII) participate in DNA damage through the generation of reactive oxygen species (ROS). We have utilized two lymphoblastic lines, Raji (B cells) and Jurkat (T cells), which were treated with the trivalent arsenic species (dose: 0-100 microM) and analyzed by two assays (comet assay and flow cytometry) in the determination of DNA damage and ROS effects in vivo. The results showed that the damage to the DNA and the generation of ROS are different in both cellular lines with respect to the dose of organic arsenic, and the order of damage is MMAIII>DMAIII>AsIII. This fact suggests that the DMAIII is not always the more cytotoxic intermediary xenobiotic, as has already been reported in another study.


Sujet(s)
Arsenic/pharmacologie , Lymphocytes B/effets des médicaments et des substances chimiques , Altération de l'ADN/effets des médicaments et des substances chimiques , Radicaux libres/pharmacologie , Composés organométalliques/pharmacologie , Lymphocytes T/effets des médicaments et des substances chimiques , Arsenic/composition chimique , Arsenic/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Test des comètes/méthodes , Relation dose-effet des médicaments , Cytométrie en flux , Radicaux libres/métabolisme , Humains , Cellules Jurkat , Composés organométalliques/métabolisme , Espèces réactives de l'oxygène/métabolisme , Rhodamines/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE